Literature DB >> 18537133

Estrogen-induced uterine abnormalities in TIMP-1 deficient mice are associated with elevated plasmin activity and reduced expression of the novel uterine plasmin protease inhibitor serpinb7.

Xuan Zhang1, Etter Hoang, Warren B Nothnick.   

Abstract

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a multifunctional protein capable of regulating a variety of biological processes in a wide array of tissue and cell types. We have previously demonstrated that TIMP-1 deficient mice exhibit alterations in normal uterine morphology and physiology. Most notably, absence of TIMP-1 is associated with an altered uterine phenotype characterized by profound branching of the uterine lumen and altered adenogenesis. To begin to assess the mechanism by which TIMP-1 may control these uterine events, we utilized steroid-treated ovariectomized wild-type and TIMP-1 null mice exposed to estrogen for 72 hr. Administration of estrogen to TIMP-1 deficient mice resulted in development of an abnormal uterine histo-architecture characterized by increased endometrial gland density, luminal epithelial cell height, and abnormal lumen structure. To determine the mediators which may contribute to the abnormal uterine morphology in the TIMP-1 deficient mice, cDNA microarray analysis was performed. Analysis revealed that expression of two plasmin inhibitors (serpbinb2 and serbinb7) was significantly reduced in the TIMP-1 null mice. Associated with the reduction in expression of these inhibitors was a significant increase in plasmin activity. Localization of the novel uterine serpinb7 revealed that expression was confined to the luminal and glandular epithelial cells. Further, expression of uterine serpinb7 was decreased by estrogen and showed an inverse relationship with plasmin activity. We conclude from these studies that in addition to controlling MMP activity, TIMP-1 may also control activity of serine proteases through modulation of serine protease inhibitors such as serpinb7. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18537133      PMCID: PMC2614461          DOI: 10.1002/mrd.20938

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  42 in total

1.  Partial purification and properties of urokinase inhibitor from human placenta.

Authors:  T Kawano; K Morimoto; Y Uemura
Journal:  J Biochem       Date:  1970-03       Impact factor: 3.387

Review 2.  Regulation of gene expression and cell function by extracellular matrix.

Authors:  P L Jones; C Schmidhauser; M J Bissell
Journal:  Crit Rev Eukaryot Gene Expr       Date:  1993       Impact factor: 1.807

3.  Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones.

Authors:  W H Rodgers; L M Matrisian; L C Giudice; B Dsupin; P Cannon; C Svitek; F Gorstein; K G Osteen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

4.  Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts.

Authors:  R F Feinberg; L C Kao; J E Haimowitz; J T Queenan; T C Wun; J F Strauss; H J Kliman
Journal:  Lab Invest       Date:  1989-07       Impact factor: 5.662

5.  Steroidal regulation of uterine edema and tissue inhibitors of metalloproteinase (TIMP)-3 messenger RNA expression is altered in TIMP-1-deficient mice.

Authors:  Warren B Nothnick; Xuan Zhang; Han-E Zhou
Journal:  Biol Reprod       Date:  2003-10-20       Impact factor: 4.285

6.  Plasminogen activator inhibitor 2: expression and role in differentiation of epidermal keratinocyte.

Authors:  Xiaohua Lian; Tian Yang
Journal:  Biol Cell       Date:  2004-03       Impact factor: 4.458

7.  The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancer.

Authors:  N Gleeson; R Gonsalves; J Bonnar
Journal:  Gynecol Oncol       Date:  1992-10       Impact factor: 5.482

8.  Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation.

Authors:  A L Hampton; L A Salamonsen
Journal:  J Endocrinol       Date:  1994-04       Impact factor: 4.286

9.  Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle.

Authors:  W H Rodgers; K G Osteen; L M Matrisian; M Navre; L C Giudice; F Gorstein
Journal:  Am J Obstet Gynecol       Date:  1993-01       Impact factor: 8.661

10.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.

Authors:  C J Sympson; R S Talhouk; C M Alexander; J R Chin; S M Clift; M J Bissell; Z Werb
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

View more
  9 in total

1.  Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Authors:  Xuan Zhang; Caitlin Healy; Warren B Nothnick
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  Maternal serum serpin B7 is associated with early spontaneous preterm birth.

Authors:  Samuel Parry; Heping Zhang; Joseph Biggio; Radek Bukowski; Michael Varner; Yaji Xu; William W Andrews; George R Saade; M Sean Esplin; Rita Leite; John Ilekis; Uma M Reddy; Yoel Sadovsky; Ian A Blair
Journal:  Am J Obstet Gynecol       Date:  2014-06-19       Impact factor: 8.661

3.  Hepatocyte growth factor system in the mouse uterus: variation across the estrous cycle and regulation by 17-beta-estradiol and progesterone.

Authors:  Xuan Zhang
Journal:  Biol Reprod       Date:  2010-02-10       Impact factor: 4.285

4.  Inhibition of macrophage migration inhibitory factor reduces endometriotic implant size in mice with experimentally induced disease.

Authors:  Warren B Nothnick; Arlene Colvin; Kai Fan Cheng; Yousef Al-Abed
Journal:  J Endometr       Date:  2011-09-30

5.  Changes in mouse uterine transcriptome in estrus and proestrus.

Authors:  Kerri Stanley Yip; Alexander Suvorov; Jeannette Connerney; Nicholas J Lodato; David J Waxman
Journal:  Biol Reprod       Date:  2013-07-18       Impact factor: 4.285

6.  Estradiol-17β-Induced Changes in the Porcine Endometrial Transcriptome In Vivo.

Authors:  Piotr Kaczynski; Stefan Bauersachs; Monika Baryla; Ewelina Goryszewska; Jolanta Muszak; Waldemar J Grzegorzewski; Agnieszka Waclawik
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

7.  Systematic identification and characterization of novel human skin-associated genes encoding membrane and secreted proteins.

Authors:  Peter Arne Gerber; Peter Hevezi; Bettina Alexandra Buhren; Cynthia Martinez; Holger Schrumpf; Marcia Gasis; Susanne Grether-Beck; Jean Krutmann; Bernhard Homey; Albert Zlotnik
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

8.  miR-451 deficiency is associated with altered endometrial fibrinogen alpha chain expression and reduced endometriotic implant establishment in an experimental mouse model.

Authors:  Warren B Nothnick; Amanda Graham; Joshua Holbert; Mitchell J Weiss
Journal:  PLoS One       Date:  2014-06-17       Impact factor: 3.240

9.  SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Authors:  Daniela Bianconi; Merima Herac; Daniel Spies; Markus Kieler; Robert Brettner; Matthias Unseld; Katrin Fürnkranz; Barbara Famler; Margit Schmeidl; Christoph Minichsdorfer; Christoph Zielinski; Gerwin Heller; Gerald W Prager
Journal:  Transl Oncol       Date:  2018-09-20       Impact factor: 4.243

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.